VANCOUVER, BC / ACCESSWIRE / June 8, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, ...

The U.S. Food and Drug Administration (FDA) recently released a draft guidance document regarding transdermal and topical delivery systems, outlining the agency’s thoughts on process and product ...

Corsair Pharma Announces Positive Phase 1 Results for the TRX-248 Transdermal System in Pulmonary Arterial Hypertension ...

Transdermal drug delivery systems (TDDS) provide a non-invasive route for systemic and local administration of therapeutic agents by traversing the skin’s outer barrier. Traditional first-generation ...

Transdermal therapeutic systems (TTSs) are commonly used to treat many diverse medical conditions. There are several advantages to this form of drug delivery; however, adverse cutaneous reactions are ...

Arcturus's mRNA medicines and vaccines and lipid-mediated drug delivery systems in combination with PassPort's innovative transdermal drug delivery system. PassPort Technologies Commences ...

Transdermal drug delivery is an alternative to oral or invasive drug delivery systems. This approach is associated with several advantages including its ability to bypass first-pass metabolism and its ...

The European Medicines Agency (EMA) has granted approval for ProStrakan Group plc to market SANCUSO® (Granisetron Transdermal System) in the European Union (EU), with 3M Drug Delivery Systems acting ...

Announcing a new publication for Acta Materia Medica journal. The prevalence of diabetes is increasing and expected to become a major global health burden. Various pharmaceutical approaches have been ...